期刊文献+

p21-激活激酶1基因在卵巢上皮性肿瘤中的过度表达及其机制和意义 被引量:12

Significance and mechanisms of overexpression of PAK1 gene in epithelial ovarian neoplasms
原文传递
导出
摘要 目的探讨p21-激活激酶1(PAK1)基因在卵巢上皮性肿瘤中的过度表达及其机制和意义。方法运用免疫组化、荧光原位杂交和末端脱氧核苷酸转移酶介导缺口末端标记方法,结合组织芯片技术,检测PAK1基因在30例卵巢腺瘤、20例卵巢交界性肿瘤和80例卵巢癌中的表达、扩增及其细胞凋亡情况。结果在免疫组化有效检测的病例中,7例(25.9%)卵巢良性腺瘤、7例(36.8%)交界性肿瘤和53例(68.8%)卵巢癌出现PAK1蛋白的过度表达,而且PAK1蛋白过表达与卵巢肿瘤的细胞凋亡指数呈负相关(P=0.002)。此外,87.1%(27/31)的低分化卵巢癌(Silverberg G3级)出现PAK1蛋白的过度表达,其过表达率显著高于G1~G2级的卵巢癌(26/46,56.5%;P= 0.01)。荧光原位杂交结果显示,只有2例(4.7%)卵巢癌出现PAK1基因扩增,卵巢交界性肿瘤和良性腺瘤均未观察到PAK1基因的扩增。结论PAK1蛋白过度表达可能在卵巢上皮性肿瘤的发生发展中起重要作用,而且与卵巢癌的恶性组织学表型密切相关;在卵巢肿瘤PAK1蛋白的表达调控中,基因扩增以外的其他调节机制可能起更为关键的作用。 Objective To investigate the significance and mechanisms of overexpression of p21- activated kinase 1 gene (PAK1) in epithelial ovarian neoplasms. Methods Immunohistochemistry, fluorescence in situ hybridization and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling methods were used to examine the protein expression and amplification of PAK1 and cell apoptosis in 30 benign ovarian adenomas, 20 borderline tumors and 80 ovarian carcinomas by tissue microarray. Results In immunohistochemistry study, overexpression of PAKI protein was observed in 7 ( 25. 9% ) informative benign ovarian adenomas, 7 (36. 8%) borderline tumors and 53 (68. 8%) ovarian carcinomas. A significant inverse correlation of PAK1 overexpression and cell apoptosis was observed in these epithelial ovarian neoplasm cohorts ( P = 0. 002 ). In addition, 27/31 ( 87. 1% ) poorly differentiated ((;3) carcinomas showed overexpression of PAK1, the frequency was significantly higher than that in tumors of G1 G2 (26/46, 56.5% , P =0.01 ). In fluorescence in situ hybridization study, only 2 (4.7%) informative ovarian carcinomas showed amplification of PAK1 gene. None of the borderline and benign ovarian tumors showed PAK1 amplification. Conclusion Overexpression of PAKI protein may be involved in the tumorigenesis of epithelial ovarian neoplasms and it is associated closely with the malignant histological phenotype of ovarian carcinomas. Mechanism other than gene amplification of PAK1 may play a more important role in the regulation of protein expression of PAK1 in ovarian tumors.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2006年第12期911-914,共4页 Chinese Journal of Oncology
基金 广东省科技计划项目资助项目(2005A30801001)
关键词 卵巢肿瘤 PAK1基因 免疫组织化学 荧光原位杂交 组织芯片 Ovarian neoplasm PAK1 gene Immunohistochemistry Fluorescence in situ hybridization Tissue microarray
  • 相关文献

参考文献12

  • 1Freund KM,Dolan NC,Nelson HD.Update in women's health.Ann Int Med,2003,138:119-127.
  • 2Rosenthal A,Jacobs I.Ovarian cancer screening.Semin Oncol,1998,25:315-325.
  • 3Schraml P,Schwerdtfeger G,Burkhalter F,et al.Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.Am J Pathol,2003,163:985-992.
  • 4Dent J,Hall GD,Wilkinson N,et al.Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation.Br J Cancer,2003,88:1578-1583.
  • 5Bagheri-Yarmand R,Mandal M,Taludker AH,et al.Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells.J Biol Chem,2001,276:29403-29409.
  • 6Neben K,Tews B,Wrobel G,et al.Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes.Oncogene,2004,23:2379-2384.
  • 7曾薇芬,詹文华,谢丹,车丽洪,林汉良,丘钜世,关新元.结直肠腺瘤-腺癌组织微阵列制作及上皮钙黏附素和β-链接素的检测[J].中华胃肠外科杂志,2001,4(3):175-178. 被引量:11
  • 8曾穗德,谢丹,林锋,王长希,陶瑜,张萌.甾体类受体共激活因子3基因在结直肠癌中的表达与扩增及其意义[J].中华胃肠外科杂志,2005,8(1):67-70. 被引量:6
  • 9Yamasaki F,Tokunaga O,Sugimori H.Apoptotic index in ovarian carcinoma:correlation with clinicopathologic factors and prognosis.Gynecol Oncol,1997,66:439-448.
  • 10Jaffer ZM,Chernoff J.p21-activated kinases:three more join the Pak.Int J Biochem Cell Biol,2002,34:713-717.

二级参考文献21

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:868
  • 2He Q J, Zeng WF, Sham JST, et al. Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients.Cancer Genet Cytogenet, 2003, 144:112-118.
  • 3Al-Mulla F, Keith WN, Pickford IR, et al. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer, 1999, 24:306-314.
  • 4Liao L, Kuang SQ, Yuan Y, et al. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1. J Steroid Biochem Mol Biol, 2003, 83:3-14.
  • 5Xie D, Zeng WF, Sham JST, et al. Heterogenous expression and association of β-Catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J cancer, 2003, 91:107-113.
  • 6Wang Y, Wu MC, Sham JST, et al. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer,2002, 95: 2346-2352.
  • 7Sakakura C, Hagiwara A, Yasuoka R, et al. Amplification and overexpression of the AIBl nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer, 2000, 89: 217-223.
  • 8Anzick SL, Kononen RL, Walker RL, et al. AIB1, a steroid receptor coactivator amplification in breast and ovarian cancer.Science, 1997, 56: 965-968.
  • 9Bouras t, Melissa C, Venter DJ. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with absence of estrogen and progesterone receptors and positivity for p53 and Her2/neu. Cancer Res, 2001, 61: 903-907.
  • 10Grossman SR, perez M, Kung AL, et al. p300/MDM2 complexes participate in the MDM2-mediated p53 degradation. Mol cell,1998, 2: 405-415.

共引文献14

同被引文献127

引证文献12

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部